en
Scientific article
English

Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland

Published inGynecologic Oncology, vol. 153, no. 1, p. 92-99
Publication date2019
Abstract

About 30% of women who are eligible for cervical cancer (CC) screening remain un-screened or under-screened in Switzerland. HPV testing on self-collected vaginal samples (Self-HPV) has shown to be more sensitive than cytology while also reaching non-attendees. The objective of this study was to explore the cost-effectiveness of offering Self-HPV to non-attendees in Switzerland.

Keywords
  • Adult
  • Cervical Intraepithelial Neoplasia/diagnosis/economics/pathology/virology
  • Cost-Benefit Analysis
  • Early Detection of Cancer/economics/methods
  • Female
  • Humans
  • Markov Chains
  • Models
  • Economic
  • Papanicolaou Test/economics/methods
  • Papillomaviridae/isolation & purification
  • Papillomavirus Infections/diagnosis/economics/virology
  • Self Care/economics/methods
  • Switzerland
  • Uterine Cervical Neoplasms/diagnosis/economics/pathology/virology
  • Vaginal Smears/economics/methods
Citation (ISO format)
VASSILAKOS, Pierre et al. Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland. In: Gynecologic Oncology, 2019, vol. 153, n° 1, p. 92–99. doi: 10.1016/j.ygyno.2019.01.021
Main files (1)
Article (Published version)
accessLevelRestricted
Secondary files (1)
Identifiers
ISSN of the journal0090-8258
213views
3downloads

Technical informations

Creation08/13/2020 2:22:00 PM
First validation08/13/2020 2:22:00 PM
Update time03/15/2023 10:53:40 PM
Status update03/15/2023 10:53:38 PM
Last indexation01/17/2024 11:18:08 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack